Par to ship generic Tambocor
Executive Summary
Par's generic version of 3M's antiarrhythmic Tambocor expected to ship within 30 days, company says May 3. Par expects to have about 150 days of generic exclusivity. The company believes generic exclusivity was triggered by an appellate court decision invalidating 3M's Tambocor patents. 3M had appealed a May 2001 Minneapolis federal court verdict in favor of Barr, which was second to file an ANDA for flecainide (1"The Pink Sheet" April 8, p. 26)...